Breast Cancer Clinical Trials in Nashville

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • Advanced Cancer
  • +2 more
  • Orlando, Florida
  • +1 more
2021-10-07
Oct 7, 2021
Z
Recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +38 more
2021-10-13
Oct 13, 2021
T
Recruiting
  • Solid Tumor
  • +3 more
  • Nashville, Tennessee
  • +2 more
2021-10-06
Oct 6, 2021
G
Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • Birmingham, Alabama
  • +28 more
2021-10-13
Oct 13, 2021
E
Recruiting
  • Locally Advanced Solid Tumor
  • +16 more
  • Birmingham, Alabama
  • +26 more
2021-10-13
Oct 13, 2021
T
Recruiting
  • Breast Cancer
  • Warrenville, Illinois
  • +11 more
2021-10-08
Oct 8, 2021
C
Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +9 more
2021-10-03
Oct 3, 2021
E
Recruiting
  • Breast Cancer
  • Los Angeles, California
  • +21 more
2021-10-04
Oct 4, 2021
T
Active, not recruiting
  • Neoplasms
  • +8 more
  • Birmingham, Alabama
  • +29 more
2021-09-08
Sep 8, 2021
P
Active, not recruiting
  • Breast Cancer
  • Kansas City, Kansas
  • +3 more
2021-09-27
Sep 27, 2021
S
Recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +29 more
2021-09-24
Sep 24, 2021
V
Not yet recruiting
  • Breast Cancer
  • Intervention plus 12 months maintenance
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
2021-09-21
Sep 21, 2021
A
Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
2021-09-15
Sep 15, 2021
S
Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Los Angeles, California
  • +10 more
2021-09-16
Sep 16, 2021
I
Active, not recruiting
  • Pancreatic Cancer
  • +3 more
  • Santa Monica, California
  • +5 more
2021-09-15
Sep 15, 2021
I
Recruiting
  • Breast Cancer
  • Renal Cell Carcinoma
  • IPI-549 (eganelisib)
  • +3 more
  • Chandler, Arizona
  • +23 more
2021-09-13
Sep 13, 2021